The Community Guide

- gsearch

Search Results

Narrow Results:

2023 1
2021 1
2020 1
2018 1
2017 1
2013 1
2011 1

United States 2

Journal Article 7

1 - 7 of 7 Results

Refine Results

Refine Results:

Incidence of Hepatitis C Virus Infection in the Human Immunodeficiency Virus Outpatient Study Cohort, 2000–2013

CITE Title : Incidence of Hepatitis C Virus Infection in the Human Immunodeficiency Virus Outpatient Study Cohort, 2000–2013 Personal Author(s) : Samandari, Taraz;Tedaldi, Ellen;Armon, Carl;Hart, Rachel;Chmiel, Joan S.;Brooks, John T.;Buchacz, Kate; Corporate Authors(s) : and the HIV Outpatient Study Investigators BuchaczKateDurhamMarcus D.BrooksT. JohnHaysHarlenHartRachelSubramanianThilakavathyArmonCarlDeanBonniePurintonStaceyFranklinDanaAkridgeCherylRayeedNabilPalellaJ. FrankChmielJoan S.JahangirSairaFlahertyConor DanielHammerJohnGreenbergKenneth S.WidickBarbaraFranklinRosaYangcoBienvenido G.WardDouglas J.ThomasTroyStewartCherylFuhrerJackOrding-BauerLindaKellyRitaEstevesJaneTedaldiEllen M.ChristianRamona A.RuleyFayeBeadleDaniaNovakRichard M.WendrowAndreaYoungBenjaminScottMiaWidickBarbara Published Date : Jun 10 2017 Source : Open Forum Infect Dis. 2017; 4(2). URL : https://stacks.cdc.gov/view/cdc/46280 Samandari, Taraz et al. (2017). Incidence of Hepatitis C Virus Infection in the Human Immunodeficiency Virus Outpatient Study Cohort, 2000–2013. 4(2). Samandari, Taraz et al. "Incidence of Hepatitis C Virus Infection in the Human Immunodeficiency Virus Outpatient Study Cohort, 2000–2013" 4, no. 2 (2017) Samandari, Taraz et al. "Incidence of Hepatitis C Virus Infection in the Human Immunodeficiency Virus Outpatient Study Cohort, 2000–2013" vol. 4, no. 2, 2017 Export RIS Citation Information.

:

Samandari, Taraz ;

Tedaldi, Ellen

Jun 10 2017 | Open Forum Infect Dis. 2017; 4(2).

:

Background.There are few recent studies of incident hepatitis C virus (HCV) infection among human immunodeficiency virus (HIV)-infected patients in th...
CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000–2009

CITE Title : CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000–2009 Personal Author(s) : Buchacz, Kate;Armon, Carl;Palella, Frank J.;Baker, Rose K.;Tedaldi, Ellen;Durham, Marcus D.;Brooks, John T.; Published Date : Sep 20 2011 Source : AIDS Res Treat. 2012; 2012. URL : https://stacks.cdc.gov/view/cdc/3778 Buchacz, Kate et al. (2011). CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000–2009. 2012 Buchacz, Kate et al. "CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000–2009" 2012 (2011) Buchacz, Kate et al. "CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000–2009" vol. 2012, 2011 Export RIS Citation Information.

:

Buchacz, Kate ;

Armon, Carl

Sep 20 2011 | AIDS Res Treat. 2012; 2012.

:

Background. It is unclear if CD4 cell counts at HIV diagnosis have improved over a 10-year period of expanded HIV testing in the USA. Methods. We stud...
Rates of suicidal ideation among HIV-infected patients in care in the HIV Outpatient Study 2000–2017, USA

CITE Title : Rates of suicidal ideation among HIV-infected patients in care in the HIV Outpatient Study 2000–2017, USA Personal Author(s) : Durham, Marcus D.;Armon, Carl;Mahnken, Jonathan D.;Novak, Richard M.;Palella, Frank J.;Tedaldi, Ellen;Buchacz, Kate; Corporate Authors(s) : HOPS Investigators Published Date : 5 2020;5-2020; Source : Prev Med. 134:106011 URL : https://stacks.cdc.gov/view/cdc/127685 Durham, Marcus D. et al. (2020). Rates of suicidal ideation among HIV-infected patients in care in the HIV Outpatient Study 2000–2017, USA. 134 Durham, Marcus D. et al. "Rates of suicidal ideation among HIV-infected patients in care in the HIV Outpatient Study 2000–2017, USA" 134 (2020) Durham, Marcus D. et al. "Rates of suicidal ideation among HIV-infected patients in care in the HIV Outpatient Study 2000–2017, USA" vol. 134, 2020 Export RIS Citation Information.

:

Durham, Marcus D. ;

Armon, Carl

5 2020 | Prev Med. 134:106011

:

Background:Suicidal ideation (SI) refers to an individual thinking about, considering or planning suicide. Identifying and characterizing persons with...
Trends of racial and ethnic disparities in virologic suppression among women in the HIV Outpatient Study, USA, 2010-2015

CITE Title : Trends of racial and ethnic disparities in virologic suppression among women in the HIV Outpatient Study, USA, 2010-2015 Personal Author(s) : Geter, Angelica;Sutton, Madeline Y.;Armon, Carl;Durham, Marcus D.;Palella, Frank J.;Tedaldi, Ellen;Hart, Rachel;Buchacz, Kate; Corporate Authors(s) : on behalf of the HIV Outpatient Study Investigators Published Date : Jan 02 2018 Source : PLoS One. 13(1). URL : https://stacks.cdc.gov/view/cdc/61213 Geter, Angelica et al. (2018). Trends of racial and ethnic disparities in virologic suppression among women in the HIV Outpatient Study, USA, 2010-2015. 13(1). Geter, Angelica et al. "Trends of racial and ethnic disparities in virologic suppression among women in the HIV Outpatient Study, USA, 2010-2015" 13, no. 1 (2018) Geter, Angelica et al. "Trends of racial and ethnic disparities in virologic suppression among women in the HIV Outpatient Study, USA, 2010-2015" vol. 13, no. 1, 2018 Export RIS Citation Information.

:

Geter, Angelica ;

Sutton, Madeline Y.

Jan 02 2018 | PLoS One. 13(1).

:

In the United States, women accounted for 19% of new HIV diagnoses in 2015 and were less likely to reach virologic suppression when compared to men. W...
Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010–2018

CITE Title : Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010–2018 Personal Author(s) : Simoncini, Gina M.;Hou, Qingjiang;Carlson, Kimberly;Buchacz, Kate;Tedaldi, Ellen;Palella, Frank;Durham, Marcus;Li, Jun; Corporate Authors(s) : HIV Outpatient Study (HOPS) Investigators Published Date : 10 2021;10-2021; Source : AIDS Patient Care STDS. 35(10):392-400 URL : https://stacks.cdc.gov/view/cdc/153447 Simoncini, Gina M. et al. (2021). Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010–2018. 35(10). Simoncini, Gina M. et al. "Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010–2018" 35, no. 10 (2021) Simoncini, Gina M. et al. "Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010–2018" vol. 35, no. 10, 2021 Export RIS Citation Information.

:

Simoncini, Gina M.

;

Hou, Qingjiang

10 2021 | AIDS Patient Care STDS. 35(10):392-400

:

Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection carries substantial risk for all-cause mortality and liver-related morbidit...
Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide

CITE Title : Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide Personal Author(s) : Palella, Frank J.;Hou, Qingjiang;Li, Jun;Mahnken, Jonathan;Carlson, Kimberly J.;Durham, Marcus;Ward, Douglas;Fuhrer, Jack;Tedaldi, Ellen;Novak, Richard;Buchacz, Kate; Published Date : 1 01 2023;1-01-; Source : J Acquir Immune Defic Syndr. 92(1):67-75 URL : https://stacks.cdc.gov/view/cdc/175439 Palella, Frank J. et al. (2023). Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide. 92(1). Palella, Frank J. et al. "Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide" 92, no. 1 (2023) Palella, Frank J. et al. "Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide" vol. 92, no. 1, 2023 Export RIS Citation Information.

:

Palella, Frank J. ;

Hou, Qingjiang

1 01 2023 | J Acquir Immune Defic Syndr. 92(1):67-75

:

Background:The timing and magnitude of antiretroviral therapy-associated weight change attributions are unclear.Setting:HIV Outpatient Study participa...
Provider Compliance With Guidelines for Management of Cardiovascular Risk in HIV-Infected Patients

CITE Title : Provider Compliance With Guidelines for Management of Cardiovascular Risk in HIV-Infected Patients Personal Author(s) : Lichtenstein, Kenneth A.;Armon, Carl;Buchacz, Kate;Chmiel, Joan S.;Buckner, Kern;Tedaldi, Ellen;Wood, Kathleen;Holmberg, Scott D.;Brooks, John T.; Corporate Authors(s) : HOPS Investigators Published Date : 2013 Source : Prev Chronic Dis. 10. URL : https://stacks.cdc.gov/view/cdc/13273 Journal Title : Preventing Chronic Disease (PCD) Lichtenstein, Kenneth A. et al. (2013). Provider Compliance With Guidelines for Management of Cardiovascular Risk in HIV-Infected Patients. 10 Lichtenstein, Kenneth A. et al. "Provider Compliance With Guidelines for Management of Cardiovascular Risk in HIV-Infected Patients" 10 (2013) Lichtenstein, Kenneth A. et al. "Provider Compliance With Guidelines for Management of Cardiovascular Risk in HIV-Infected Patients" vol. 10, 2013 Export RIS Citation Information.

:

Lichtenstein, Kenneth A. ;

Armon, Carl

2013 | Prev Chronic Dis. 10.

:

IntroductionCompliance with National Cholesterol Education Program Adult Treatment Panel III (NCEP) guidelines has been shown to significantly reduce ...